£84.88

CRC Press Multiple Myeloma: Translational and Emerging Therapies (Translational Medicine)

Price data last checked 72 day(s) ago - refreshing...

View at Amazon

We'll watch every seller, every day. One email when your price arrives.

About as cheap as it gets. The only time it was cheaper was 3 months ago.

£85 today · all-time low £85 (Apr 2026) · usually the usual

NEW HERE?

Amazon shows you one price. We show you all of them.

Tosheroon watches Amazon prices so you don't have to. Every product on Amazon has a price history — we make it visible. Set the price you'd actually pay, and we'll email you the second it gets there. No app, no account, one email.

WHAT'S ON THIS PAGE

↓ Price chart
when this has been cheap or pricey
↓ Forecast
where the price is heading next
↓ Statistics
all-time high & low, recent range
↑ Price alert
name your number, we'll email you

Price History & Forecast

Grey patches = out of stock. Cheaper = lower on the chart. Hover for exact prices.

Last 19 days • 19 data points (No recent data available)

Historical
Generating forecast...
£84.89 £84.85 £84.86 £84.87 £84.87 £84.88 £84.89 08 April 2026 12 April 2026 17 April 2026 21 April 2026 26 April 2026

Price Distribution

Price distribution over 19 days • 1 price levels

Days at Price
19 days 0 5 10 14 19 £85 Days at Price

Price Analysis

Most common price: £85 (19 days, 100.0%)

Price range: £85 - £85

Price levels: 1 different prices over 19 days

Description

Multiple myeloma is the second most prevalent hematological malignancy, with over 55,000 new cases diagnosed each year. This exciting new text, edited by lauded authorities on the topic, stands as the only available reference to assemble, review, and synthesizes the latest studies on translational therapies and clearly explains the impact of molecular pathogenesis, biology, and prognostic factors on the diagnosis, prognosis, and individualization of treatment and the development of novel therapeutic options for patients with myeloma. Moving from the bench to the bedside to the forefront of therapeutic development, this source: helps clinicians and researchers effectively deploy therapeutic strategies into clinical practice reflects trends in the use of agents which target both the tumor cell and its bone marrow microenvironment to overcome resistance to conventional therapies considers the critical role of the bone marrow microenvironment in the regulation of growth, survival, and homing of multiple myeloma discusses novel therapies in phase I and phase II trials, focusing specifically on therapeutic options for patients with newly diagnosed or relapsed/refractory multiple myeloma addresses novel therapies for other plasma cell disorders, and provides the framework for the design of next generation agents and combination therapies covers the entire scope of translational work in multiple myeloma, from advances in molecular pathogenesis, to prognostic factors, immunotherapy, and new options for newly diagnosed and relapsed multiple myeloma patients

Product Specifications

Format
hardcover
Domain
Amazon UK
Release Date
11 October 2007
Listed Since
05 January 2007

Barcode

No barcode data available

Similar Products You Might Like

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
98% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£84.29 08 Mar 2026
Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside
98% match

Bone Cancer: Bone Sarcomas and Bone Metastases - From Bench to Bedside

Academic Press

£168.99 19 Jun 2026
Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)
97% match

Multiple Myeloma: 183 (Recent Results in Cancer Research, 183)

Springer

£103.09 11 Jun 2026
Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)
97% match

Multiple Myeloma and Other Plasma Cell Neoplasms: 0 (Hematologic Malignancies)

Springer

£99.39 02 Jul 2026
Treatment of Multiple Myeloma and Related Disorders
97% match

Treatment of Multiple Myeloma and Related Disorders

Cambridge University Press

£36.41 04 Jul 2026
Springer Multiple Myeloma and Plasma Cell Neoplasms Book
97% match

Springer Multiple Myeloma and Plasma Cell Neoplasms Book

Springer

£104.18 28 Apr 2026
Multiple Myeloma and Related Disorders (Hodder Arnold Publication)
97% match

Multiple Myeloma and Related Disorders (Hodder Arnold Publication)

CRC Press

£150.17 12 Jun 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£103.24 12 Jun 2026
Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)
97% match

Multiple Myeloma: Methods and Protocols: 1792 (Methods in Molecular Biology, 1792)

Humana

£79.19 06 May 2026
Springer - Advances in Biology and Therapy of Multiple Myeloma 2
97% match

Springer - Advances in Biology and Therapy of Multiple Myeloma 2

Springer

£107.98 05 May 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£100.08 03 Jul 2026
Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)
97% match

Multiple Myeloma: Symptoms, Diagnosis and Treatment (Cancer Etiology, Diagnosis and Treatments Series)

£91.41 10 Mar 2026
Clinical Malignant Hematology
97% match

Clinical Malignant Hematology

McGraw-Hill Education

£201.99 17 Jun 2026
Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)
97% match

Resistance to Targeted Therapies in Multiple Myeloma: 22 (Resistance to Targeted Anti-Cancer Therapeutics, 22)

Springer

£99.71 22 Apr 2026
Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)
96% match

Diagnostic and Therapeutic Advances in Hematologic Malignancies: 99 (Cancer Treatment and Research, 99)

Springer

£248.00 17 Jun 2026
Horizons in Cancer Research. Volume 73: Volume 73
96% match

Horizons in Cancer Research. Volume 73: Volume 73

£113.87 13 Jun 2026
Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)
96% match

Bortezomib in the Treatment of Multiple Myeloma (Milestones in Drug Therapy)

Springer

£84.56 01 May 2026
Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)
96% match

Multiple Myeloma: Methods and Protocols: 113 (Methods in Molecular Medicine, 113)

Humana

£31.08 07 Mar 2026
Consulting Hematology and Oncology Handbook
96% match

Consulting Hematology and Oncology Handbook

Springer

£57.66 08 Mar 2026
Springer Hematologic Cancers: Molecular Pathobiology to Therapy
96% match

Springer Hematologic Cancers: Molecular Pathobiology to Therapy

Springer

£113.48 20 Apr 2026
The International Consensus Classification of Myeloid and Lymphoid Neoplasms
96% match

The International Consensus Classification of Myeloid and Lymphoid Neoplasms

Lippincott Williams & Wilkins

£117.11 02 Jul 2026
Comprehensive Hematology and Stem Cell Research
96% match

Comprehensive Hematology and Stem Cell Research

Elsevier

£1,712.72 18 Jun 2026
Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders
96% match

Hematologic Malignancies: Multiple Myeloma and Related Plasma Cell Disorders

Springer

£140.56 13 Jun 2026
Contemporary Management of Multiple Myeloma
96% match

Contemporary Management of Multiple Myeloma

Jaypee Brothers Medical Publishers

£11.49 07 Jul 2026